索诺玛制药(NASDAQ:SNOA)报告季度每股亏损$(0.63)，优于分析师一致预期的$(0.69)，增长率为8.7%。这是比去年同期每股亏损$(1.60)增加了60.63%。公司报告季度销售额为$3.564，未达分析师一致预期的$4.060百万，差距为100.00%。这比去年同期的销售额$3.138百万下降了100.00%。
以上内容来自Benzinga Earnings专栏，原文如下：
Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.63) per share which beat the analyst consensus estimate of $(0.69) by 8.7 percent. This is a 60.63 percent increase over losses of $(1.60) per share from the same period last year. The company reported quarterly sales of $3.564 which missed the analyst consensus estimate of $4.060 million by 100.00 percent. This is a 100.00 percent decrease over sales of $3.138 million the same period last year.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。